Active exploits, nation-state campaigns, fresh arrests, and critical CVEs — this week's cybersecurity recap has it all.
LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL ® ON, an ongoing five-year open-label extension study of the pivotal ...
Claude extension flaw enabled silent prompt injection via XSS and weak allowlist, risking data theft and impersonation until ...